Teva Talks at Biomed: New Technologies on the Horizon – Menashe Y. Levy, PhD

Menashe Y. Levy, PhD, is the VP, Chief Technology Officer, Global R&D at Teva.
His presentation describes Teva’s proactive strategy to address the emerging unmet clinical needs by incorporating new enabling technologies into our pipeline.
With 25 years of experience in the biotechnology, devices and pharmaceutical industries, Menashe’s role as CTO at Teva allows him to explore the incorporation of novel enabling technologies, and novel science approaches into our generic, specialty and NTE pipelines.

source